Literature DB >> 8616888

Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells.

L Li1, S N Cohen.   

Abstract

Using a novel strategy that enables the isolation of previously unknown genes encoding selectable recessive phenotypes, we identified a gene (tsg101) whose homozygous functional disruption produces cell transformation. Antisense RNA from a transactivated promoter introduced randomly into transcribed genes throughout the genome of mouse 3T3 fibroblasts was used to knock out alleles of chromosomal genes adjacent to promoter inserts, generating clones that grew in 0.5% agar and formed metastatic tumors in nude mice. Removal of the transactivator restored normal growth. The protein encoded by tsg101 cDNA encodes a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated previously in tumorigenesis. Overexpression of tsg101 antisense transcripts in naive 3T3 cells resulted in cell transformation and increased stathmin-specific mRNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616888     DOI: 10.1016/s0092-8674(00)81111-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  107 in total

1.  The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development.

Authors:  J D Alvarez; D H Yasui; H Niida; T Joh; D Y Loh; T Kohwi-Shigematsu
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

2.  Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding.

Authors:  Ido Amit; Liat Yakir; Menachem Katz; Yaara Zwang; Mina D Marmor; Ami Citri; Keren Shtiegman; Iris Alroy; Shmuel Tuvia; Yuval Reiss; Eli Roubini; Maya Cohen; Ron Wides; Eran Bacharach; Ullrich Schubert; Yosef Yarden
Journal:  Genes Dev       Date:  2004-07-15       Impact factor: 11.361

Review 3.  Defective downregulation of receptor tyrosine kinases in cancer.

Authors:  Kristi G Bache; Thomas Slagsvold; Harald Stenmark
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

4.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

Review 5.  The ESCRT complexes.

Authors:  James H Hurley
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-07-23       Impact factor: 8.250

6.  Basic residues in the nucleocapsid domain of Gag are critical for late events of HIV-1 budding.

Authors:  Vincent Dussupt; Paola Sette; Nana F Bello; Melodi P Javid; Kunio Nagashima; Fadila Bouamr
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

7.  Crystallographic and functional analysis of the ESCRT-I /HIV-1 Gag PTAP interaction.

Authors:  Young Jun Im; Lillian Kuo; Xuefeng Ren; Patricia V Burgos; Xue Zhi Zhao; Fa Liu; Terrence R Burke; Juan S Bonifacino; Eric O Freed; James H Hurley
Journal:  Structure       Date:  2010-11-10       Impact factor: 5.006

8.  Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release.

Authors:  Charles Langelier; Uta K von Schwedler; Robert D Fisher; Ivana De Domenico; Paul L White; Christopher P Hill; Jerry Kaplan; Diane Ward; Wesley I Sundquist
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

9.  A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles.

Authors:  Sang-Hyuk Chung; Kristopher K Frese; Robert S Weiss; B V Venkataram Prasad; Ronald T Javier
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

10.  FGI-104: a broad-spectrum small molecule inhibitor of viral infection.

Authors:  Michael S Kinch; Abdul S Yunus; Calli Lear; Hanwen Mao; Hanson Chen; Zena Fesseha; Guangxiang Luo; Eric A Nelson; Limin Li; Zhuhui Huang; Michael Murray; William Y Ellis; Lisa Hensley; Jane Christopher-Hennings; Gene G Olinger; Michael Goldblatt
Journal:  Am J Transl Res       Date:  2009-01-05       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.